Abi is a European and UK qualified patent attorney and an Associate in our Life Sciences and Chemistry group. Abi leverages her experience in biologics and cancer research for clients across the field of Life Sciences, with particular expertise in antibodies and next generation sequencing technologies. Other key areas of practice include vaccines, cancer therapies, biomarkers and microbiology.
Abi employs a client-centric approach, providing practical, commercially focussed advice to a diverse range of clients; from small start-ups to large multinationals. Abi works closely with her clients on both complex prosecution matters and commercially important oppositions, as well as drafting and prosecuting patent applications in the UK and Europe. A number of Abi's clients are start-ups, and Abi works closely with the leadership teams to co-ordinate worldwide patent prosecution and overall IP strategies, and advise on due diligence matters. She also has valuable in-house experience gained during a year-long client secondment which culminated in the successful acquisition of the UK start-up client by a large multinational company.
Abi attended Brasenose College, University of Oxford, where in 2016 she graduated with a MBiochem (Hons) degree in Molecular and Cellular Biochemistry. Abi’s master’s research project at The William Dunn School of Pathology focussed on investigating the interactions of the human Notch1 receptor. Abi lectures for the CIPA Foundations program and leads tutorials on European and UK patent law for students studying for Qualifying Examinations.